Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayApr 10, 2019 9:20 am

NetworkNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Issues Update on Cannabis Facility Acquisition

TransCanna Holdings (CSE: TCAN) (FSE: TH8), an emerging cannabis branding, transportation and distribution company based in Canada, this morning provided an update concerning the company’s acquisition of a 196,000-square-foot vertically integrated cannabis facility. Per the update, TransCanna expects the closing of escrow for the acquisition to take place on or around Monday, April 15th. The company intends to provide an additional update upon the successful completion of the acquisition. To view the full press release, visit http://nnw.fm/4jQcu About TransCanna Holdings Inc. TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California…

Continue Reading

TuesdayApr 09, 2019 3:20 pm

NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Streamlines FlowrRX Product Availability through Agreement with Shoppers Drug Mart

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) recently announced that its FlowrRX products are officially available for purchase through the Shoppers Drug Mart online medical cannabis platform. An article discussing FLWPF reads, “The two companies confirmed a sales agreement at the beginning of 2019. Through the partnership, The Flowr Corporation and Shoppers Drug Mart are simplifying the delivery of medical cannabis products in Canada. . . . ‘Flowr’s premium medical cannabis is grown in what we believe is the industry’s most advanced GMP designed cultivation facility. This relationship is testament to our commitment to ultra-high-quality cannabis cultivation and further solidifies…

Continue Reading

TuesdayApr 09, 2019 3:04 pm

NetworkNewsBreaks – Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) Takes Advantage of New Vertical Market Opportunity via Joint Venture

Kontrol Energy (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8), a leader in the energy efficiency sector, recently entered into an agreement with Toyota Tsusho Canada Inc. (“TTCI”) to create a company that provides technological solutions and services to Original Equipment Manufacturer (“OEM”) clients operating in the automotive sector. A recent article discussing KNRLF reads, “The Ontario, Canada-based disruptive digital tech company is attuning the power of its IoT product base to the automotive industry through a planned joint venture with Toyota Tsusho Canada Inc. (“TTCI”) that is expected to scale across North America on the heels of Kontrol’s announced entry into…

Continue Reading

TuesdayApr 09, 2019 2:39 pm

NetworkNewsBreaks – Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Advancing Shymanivske Project Development

Black Iron (TSX: BKI) (OTC: BKIRF) (GR: BIN), a Canadian iron ore exploration and development company, is making strides in the development of its 100 percent owned Shymanivske iron ore deposit advantageously located in Kryvyi Rih, Ukraine. An article discussing the company reads, “Black Iron recently announced positive momentum in its search for a parcel of land suitable for the company’s processing plant, tailings and waste rock associated with the Shymanivske project (http://nnw.fm/xA5Gl). . . . In a recent news release, Black Iron noted that Ukraine’s Ministry of Defense (“MOD”) has developed a plan to transfer the parcel of land outlined…

Continue Reading

TuesdayApr 09, 2019 9:36 am

NetworkNewsBreaks – Liberty Defense Holdings, Ltd. (TSX.V: SCAN) Commences Trading on the TSX Venture Exchange

Following completion of a reverse take-over, security solutions and technology company Liberty Defense Holdings (TSX.V: SCAN) today announced that its common shares have commenced trading under the symbol "SCAN" on the TSX Venture Exchange. “We are delighted to be able to commence trading on the TSX Venture under the symbol ‘SCAN’. The completion of the recent reverse takeover and associated financing means that we are well placed to be able to achieve our business objectives in 2019,” Liberty Defense Holdings CEO Bill Riker said in the news release. “We are already having exceptional interest in our HEXWAVE product and look…

Continue Reading

TuesdayApr 09, 2019 9:30 am

NetworkNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) CEO to Present at the Cambridge Healthtech Institute’s Inflammation Inhibitors Conference

INmune Bio (NASDAQ: INMB) this morning announced that the company’s co-founder and CEO Dr. RJ Tesi will be presenting at the Cambridge Healthtech Institute’s Inflammation Inhibitors Conference on April 11th at 4:50 PM in San Diego. Dr. Tesi’s presentation titled, “Targeting Soluble TNF to Eliminate Chronic Inflammation without Immunosuppression,” will discuss targeting soluble tumor necrosis factor (“TNF”) to remove chronic inflammation without immunosuppression. “Inflammation, especially chronic inflammation, is being recognized as an important part of the pathophysiology of many diseases, including cancer and Alzheimer’s disease,” INmune Bio co-founder and CEO Dr. RJ Tesi stated in the news release. “Drugs targeting…

Continue Reading

TuesdayApr 09, 2019 9:29 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Renews Senior Management Contracts, Cancels Options

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning announced its successful negotiation of renewal management contracts with chief executive officer Chris Bunka and president John Docherty. According to the update, the new 3-year term contracts, for which specific details can be found within regulatory filings, provide management continuity during this period of corporate growth while allowing the company to seamlessly pursue its business goals and create shareholder value. In addition, Lexaria announced that, effective April 5, 2019, it has reached agreements with certain optionees to cancel 1,140,000 stock options with exercise prices ranging…

Continue Reading

TuesdayApr 09, 2019 9:00 am

NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Appoints Cannabis Industry Veteran with Passion, Deep Expertise to its Board

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) recently announced its appointment of Nicholas J. Zitelli to its board of directors. Zitelli is currently part-owner, director, and chief cannabis officer of Trans High Corporation (“THC”), the parent company for all HIGH TIMES brands, and is also the founder and CEO of the Cannabis Genetics Institute (“CGI”), a well-established research and development institution. Zitelli has authored hundreds of articles since 2007, under the penname of "Nico Escondido,” covering all cannabis science and technology aspects and garnering a reputation as an industry expert in the areas of garden technologies, cultivation, genetics, lab testing, and…

Continue Reading

MondayApr 08, 2019 12:33 pm

NetworkNewsBreaks – GENFIT S.A. (NASDAQ: GNFT) Secures Gross Proceeds of Approximately $155.4 Million through Initial Public Offering

French biopharmaceutical company GENFIT S.A. (NASDAQ: GNFT) recently closed its initial public offering of 7,647,500 new ordinary shares, including an additional 997,500 ADSs pursuant to the full exercise of the over-allotment option granted to the underwriters. The offering, which resulted in gross proceeds of approximately $155.4 million for GENFIT S.A., was comprised of 7,147,500 American Depositary Shares, each representing one ordinary share (“ADSs”), at a public offering price of $20.32 per ADS, and a concurrent private placement of 500,000 ordinary shares in Europe (including France) and countries outside of the United States at the corresponding offering price of €18.00 per…

Continue Reading

MondayApr 08, 2019 11:46 am

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Collaborators Report Positive Preclinical Data at 2019 AACR Annual Meeting

Clinical-stage gene therapy company Genprex Inc. (NASDAQ: GNPX) this morning announced that its collaborators from the University of Texas MD Anderson Cancer Center (“MD Anderson”) detailed positive preclinical data, in a poster presented at the American Association of Cancer Research Meeting 2019, regarding the combination of the TUSC2 gene with an anti-PD1 antibody, pembrolizumab, for the treatment of lung cancer. TUSC2 is a tumor suppressor gene and the active agent in Genprex’s Oncoprex immunogene therapy. “Development of an improved humanized patient-derived xenograft, Hu-PDX, mouse model for evaluation of antitumor immune response in lung cancer,” was the title of the poster,…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000